Journal article
Identification of novel HIV-1-derived HLA-E-binding peptides
- Abstract:
- Non-classical class Ib MHC-E molecule is becoming an increasingly interesting component of the immune response. It is involved in both the adaptive and innate immune responses to several chronic infections including HIV-1 and, under very specific circumstances, likely mediated a unique vaccine protection of rhesus macaques against pathogenic SIV challenge. Despite being recently in the spotlight for HIV-1 vaccine development, to date there is only one reported human leukocyte antigen (HLA)-E-binding peptide derived from HIV-1. In an effort to help start understanding the possible functions of HLA-E in HIV-1 infection, we determined novel HLA-E binding peptides derived from HIV-1 Gag, Pol and Vif proteins. These peptides were identified in three independent assays, all quantifying cell-surface stabilization of HLA-E*01:01 or HLA-E*01:03 molecules upon peptide binding, which was detected by HLA-E-specific monoclonal antibody and flow cytometry. Thus, following initial screen of over 400 HIV-1-derived 15-mer peptides, 4 novel 9-mer peptides PM9, RL9, RV9 and TP9 derived from 15-mer binders specifically stabilized surface expression of HLA-E*01:03 on the cell surface in two separate assays and 5 other binding candidates EI9, MD9, NR9, QF9 and YG9 gave a binding signal in only one of the two assays, but not both. Overall, we have expanded the current knowledge of HIV-1-derived target peptides stabilizing HLA-E cell-surface expression from 1 to 5, thus broadening inroads for future studies. This is a small, but significant contribution towards studying the fine mechanisms behind HLA-E actions and their possible use in development of a new kind of vaccines.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 1.2MB, Terms of use)
-
- Publisher copy:
- 10.1016/j.imlet.2018.08.005
Authors
- Publisher:
- Elsevier
- Journal:
- Immunology Letters More from this journal
- Volume:
- 202
- Pages:
- 65-72
- Publication date:
- 2018-08-30
- Acceptance date:
- 2018-08-23
- DOI:
- EISSN:
-
1879-0542
- ISSN:
-
0165-2478
- Pmid:
-
30172717
- Language:
-
English
- Keywords:
- Pubs id:
-
pubs:915392
- UUID:
-
uuid:15d3f57a-8eb0-41b3-a05c-b0c139f58593
- Local pid:
-
pubs:915392
- Source identifiers:
-
915392
- Deposit date:
-
2018-09-25
- ARK identifier:
Terms of use
- Copyright holder:
- Hannoun et al
- Copyright date:
- 2018
- Notes:
- © 2018 The Authors. Published by Elsevier B.V. on behalf of European Federation of Immunological Societies. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).
If you are the owner of this record, you can report an update to it here: Report update to this record